BOLT
Price
$5.70
Change
+$0.06 (+1.06%)
Updated
Aug 8, 01:31 PM (EDT)
Capitalization
10.81M
CLSD
Price
$0.42
Change
+$0.04 (+10.53%)
Updated
Aug 8, 04:21 PM (EDT)
Capitalization
32.04M
10 days until earnings call
Interact to see
Advertisement

BOLT vs CLSD

Header iconBOLT vs CLSD Comparison
Open Charts BOLT vs CLSDBanner chart's image
Bolt Biotherapeutics
Price$5.70
Change+$0.06 (+1.06%)
Volume$660
Capitalization10.81M
Clearside Biomedical
Price$0.42
Change+$0.04 (+10.53%)
Volume$13.2K
Capitalization32.04M
BOLT vs CLSD Comparison Chart in %
Loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLT vs. CLSD commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a Hold and CLSD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BOLT: $5.64 vs. CLSD: $0.38)
Brand notoriety: BOLT and CLSD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 42% vs. CLSD: 10%
Market capitalization -- BOLT: $10.81M vs. CLSD: $32.04M
BOLT [@Biotechnology] is valued at $10.81M. CLSD’s [@Biotechnology] market capitalization is $32.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileCLSD’s FA Score has 0 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • CLSD’s FA Score: 0 green, 5 red.
According to our system of comparison, BOLT is a better buy in the long-term than CLSD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 3 TA indicator(s) are bullish while CLSD’s TA Score has 5 bullish TA indicator(s).

  • BOLT’s TA Score: 3 bullish, 6 bearish.
  • CLSD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CLSD is a better buy in the short-term than BOLT.

Price Growth

BOLT (@Biotechnology) experienced а -0.18% price change this week, while CLSD (@Biotechnology) price change was -8.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.05%. For the same industry, the average monthly price growth was +6.44%, and the average quarterly price growth was +13.10%.

Reported Earning Dates

CLSD is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+0.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLSD($32M) has a higher market cap than BOLT($10.8M). BOLT YTD gains are higher at: -47.300 vs. CLSD (-59.684). CLSD has higher annual earnings (EBITDA): -19.77M vs. BOLT (-61.54M). BOLT has more cash in the bank: 38.8M vs. CLSD (13.6M). CLSD has less debt than BOLT: CLSD (619K) vs BOLT (24.7M). CLSD (3.76M) and BOLT (3.64M) have equivalent revenues.
BOLTCLSDBOLT / CLSD
Capitalization10.8M32M34%
EBITDA-61.54M-19.77M311%
Gain YTD-47.300-59.68479%
P/E RatioN/AN/A-
Revenue3.64M3.76M97%
Total Cash38.8M13.6M285%
Total Debt24.7M619K3,990%
FUNDAMENTALS RATINGS
CLSD: Fundamental Ratings
CLSD
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLTCLSD
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 17 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GALT3.820.05
+1.33%
Galectin Therapeutics
KFFB3.120.04
+1.20%
Kentucky First Federal Bancorp
CTS38.570.16
+0.42%
CTS Corp
FELE93.33-0.51
-0.54%
Franklin Electric Co
INFY16.02-0.18
-1.11%
Infosys Limited

BOLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLT has been loosely correlated with XENE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLT jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
+0.53%
XENE - BOLT
38%
Loosely correlated
-1.84%
ELVN - BOLT
37%
Loosely correlated
-4.99%
ATXS - BOLT
36%
Loosely correlated
-4.44%
SYRE - BOLT
34%
Loosely correlated
-4.51%
BHVN - BOLT
33%
Loosely correlated
+1.13%
More

CLSD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLSD has been loosely correlated with ABVX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CLSD jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSD
1D Price
Change %
CLSD100%
-7.11%
ABVX - CLSD
52%
Loosely correlated
-1.26%
NEVPF - CLSD
35%
Loosely correlated
N/A
ANEB - CLSD
31%
Poorly correlated
-11.11%
IMNN - CLSD
30%
Poorly correlated
+1.21%
BOLT - CLSD
29%
Poorly correlated
+0.53%
More